NCT02139228View on ClinicalTrials.gov

Persistency Study After Hib-CRM (Cross-Reacting Material)197 or Hib-TT (Tetanus Toxoid) Vaccines in Chinese Children

PHASE3CompletedINTERVENTIONAL
Enrollment

426

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

January 31, 2015

Conditions
Meningitis, Epiglottitis, Pneumonia, Arthritis Caused by Haemophilus Influenzae Type b
Interventions
BIOLOGICAL

Hib-CRM197

No vaccine administered in V37\_07E2 study

BIOLOGICAL

Hib-TT

No vaccine administered in V37\_07E2 study

Trial Locations (1)

050021

DingXing Center for Disease Control and Prevention, Dingxing

Sponsors

Lead Sponsor

Novartis Vaccines
All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY